Cargando…
Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease
AIM: Genetic contribution in acute rheumatic fever (ARF)/rheumatic heart disease (RHD) has been suggested but not according to severity of the valve involvement. This study attempts to identify the relevance of CTLA-4 polymorphism with severity of the disease. METHODS: In a case-control design, 291...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424281/ https://www.ncbi.nlm.nih.gov/pubmed/34474769 http://dx.doi.org/10.1016/j.ihj.2021.05.002 |
_version_ | 1783749643833704448 |
---|---|
author | Bansal, Ankit Tasnim, Sana Gupta, Mohit D. MP, Girish Batra, Vishal Kohli, Samantha Tyagi, Sanjay Pasha, M.A. Qadar |
author_facet | Bansal, Ankit Tasnim, Sana Gupta, Mohit D. MP, Girish Batra, Vishal Kohli, Samantha Tyagi, Sanjay Pasha, M.A. Qadar |
author_sort | Bansal, Ankit |
collection | PubMed |
description | AIM: Genetic contribution in acute rheumatic fever (ARF)/rheumatic heart disease (RHD) has been suggested but not according to severity of the valve involvement. This study attempts to identify the relevance of CTLA-4 polymorphism with severity of the disease. METHODS: In a case-control design, 291 healthy controls and 83 patients were genotyped for association between RHD and single-nucleotide polymorphisms −1661A/G of CTLA-4. RESULTS: Segregation of patients on the basis of severity i.e., MVL (Mitral Valve Lesion) and CVL (Combined Valve Lesion) revealed that the frequency of CTLA-4 −1661G allele depleted as the disease progressed to CVL (p < 0.05). Patients in the age group of 31–45 years were significantly more susceptible (p < 0.046). Whereas, female patients were more susceptible than the male patients. CONCLUSION: Our study suggests the risk associated with decreased frequency of CTLA-4 −1661G allele in the CVL group and in females. |
format | Online Article Text |
id | pubmed-8424281 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84242812021-09-13 Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease Bansal, Ankit Tasnim, Sana Gupta, Mohit D. MP, Girish Batra, Vishal Kohli, Samantha Tyagi, Sanjay Pasha, M.A. Qadar Indian Heart J Research Brief AIM: Genetic contribution in acute rheumatic fever (ARF)/rheumatic heart disease (RHD) has been suggested but not according to severity of the valve involvement. This study attempts to identify the relevance of CTLA-4 polymorphism with severity of the disease. METHODS: In a case-control design, 291 healthy controls and 83 patients were genotyped for association between RHD and single-nucleotide polymorphisms −1661A/G of CTLA-4. RESULTS: Segregation of patients on the basis of severity i.e., MVL (Mitral Valve Lesion) and CVL (Combined Valve Lesion) revealed that the frequency of CTLA-4 −1661G allele depleted as the disease progressed to CVL (p < 0.05). Patients in the age group of 31–45 years were significantly more susceptible (p < 0.046). Whereas, female patients were more susceptible than the male patients. CONCLUSION: Our study suggests the risk associated with decreased frequency of CTLA-4 −1661G allele in the CVL group and in females. Elsevier 2021 2021-06-08 /pmc/articles/PMC8424281/ /pubmed/34474769 http://dx.doi.org/10.1016/j.ihj.2021.05.002 Text en © 2021 Cardiological Society of India. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Brief Bansal, Ankit Tasnim, Sana Gupta, Mohit D. MP, Girish Batra, Vishal Kohli, Samantha Tyagi, Sanjay Pasha, M.A. Qadar Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease |
title | Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease |
title_full | Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease |
title_fullStr | Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease |
title_full_unstemmed | Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease |
title_short | Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease |
title_sort | susceptibility of ctla-4 −1661a/g polymorphism towards severity of rheumatic heart disease |
topic | Research Brief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424281/ https://www.ncbi.nlm.nih.gov/pubmed/34474769 http://dx.doi.org/10.1016/j.ihj.2021.05.002 |
work_keys_str_mv | AT bansalankit susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease AT tasnimsana susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease AT guptamohitd susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease AT mpgirish susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease AT batravishal susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease AT kohlisamantha susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease AT tyagisanjay susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease AT pashamaqadar susceptibilityofctla41661agpolymorphismtowardsseverityofrheumaticheartdisease |